These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 693501)

  • 21. Mechanism of the hypoglycaemia caused by hypoglycin and pent-4-enoate.
    Billington D
    Biochem Soc Trans; 1979 Feb; 7(1):106-11. PubMed ID: 437248
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibition of apple 1-aminocyclopropane-1-carboxylic acid oxidase, by cyclopropane-1,1-dicarboxylic acid and trans-2-phenylcyclopropane-1-carboxylic acid.
    Dourtoglou V; Koussissi E
    Phytochemistry; 2000 Oct; 55(3):203-11. PubMed ID: 11142843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Some effects of alpha-bromopalmitate, an inhibitor of fatty acid oxidation, on carbohydrate metabolism in the rat.
    Burges RA; Butt WD; Baggaley A
    Biochem J; 1968 Sep; 109(3):38P-39P. PubMed ID: 5685864
    [No Abstract]   [Full Text] [Related]  

  • 24. On the mechanisms of some pharmacological actions of the hypoglycaemic toxins hypoglycin and pent-4-enoic acid. A way out of the present confusion.
    Stanley H; Sherratt A; Osmundsen H
    Biochem Pharmacol; 1976 Apr; 25(7):743-50. PubMed ID: 938577
    [No Abstract]   [Full Text] [Related]  

  • 25. Investigation of hepatic ATP and glucose 6-phosphate as indices of hypoglycin toxicity.
    Kean EA; Rainford IJ
    Biochim Biophys Acta; 1973 Jan; 297(1):31-6. PubMed ID: 4693520
    [No Abstract]   [Full Text] [Related]  

  • 26. The antagonism of the toxicity of hypoglycin by glycine.
    Al-Bassam SS; Sherratt HS
    Biochem Pharmacol; 1981 Oct; 30(20):2817-24. PubMed ID: 7317076
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on the regulation of leucine catabolism. II. Mechanism responsible for dichloroacetate stimulation of leucine oxidation by the liver.
    Harris RA; Crabb DW; Sans RM
    Arch Biochem Biophys; 1978 Sep; 190(1):8-16. PubMed ID: 708080
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition of 5-oxoprolinase by 2-imidazolidone-4-carboxylic acid.
    Van der Werf P; Stephani RA; Orlowski M; Meister A
    Proc Natl Acad Sci U S A; 1973 Mar; 70(3):759-61. PubMed ID: 4514988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the inhibition of hepatic lipogenesis by carboxylic acids.
    Harris RA; McCune SA
    Biochem Soc Trans; 1980 Oct; 8(5):562-3. PubMed ID: 6778740
    [No Abstract]   [Full Text] [Related]  

  • 30. [Influence of low concentrations of fluothane on the structure and metabolism of some organs in experiments].
    Krechkovskiĭ EA; Kiseleva AF; Kolesova NA; Anisimova IG
    Eksp Khir Anesteziol; 1976; (1):71-4. PubMed ID: 1261479
    [No Abstract]   [Full Text] [Related]  

  • 31. Postanesthetic hypotension following cyclopropane; its relationship to hypercapnia.
    BUCKLEY JJ; VAN BERGEN FH; DOBKIN AB; BROWN EB; MILLER FA; VARCO RL
    Anesthesiology; 1953 May; 14(3):226-37. PubMed ID: 13040805
    [No Abstract]   [Full Text] [Related]  

  • 32. Carbon dioxide fixation by rat heart muscle in vivo.
    HALL HE; HAWTHORNE EW; MARSHALL LM
    Am J Physiol; 1953 May; 173(2):335-6. PubMed ID: 13065451
    [No Abstract]   [Full Text] [Related]  

  • 33. Myocardial excitability of dogs during cyclopropane anesthesia: effect of diffusion respiration.
    GRAFF TD; HARRIS LC; ARBEGAST NR; PHILLIPS OC
    Anesth Analg; 1960; 39():293-301. PubMed ID: 13828755
    [No Abstract]   [Full Text] [Related]  

  • 34. Structure-activity relationship in synthetic fibrinolytics. 2-Phenethynylcyclopropanecarboxylates.
    Yoshimoto M; von Kaulla KN; Hansch C
    J Med Chem; 1975 Sep; 18(9):950-1. PubMed ID: 1159718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heart block and cyclopropane.
    COWAN KA
    Anaesthesia; 1954 Apr; 9(2):114-5. PubMed ID: 13148569
    [No Abstract]   [Full Text] [Related]  

  • 36. Interference by organic acids in CO2 measurement in the Kodak Ektachem 400.
    Jack RM
    Clin Chem; 1988 Jun; 34(6):1361. PubMed ID: 3132337
    [No Abstract]   [Full Text] [Related]  

  • 37. EFFECTS OF CYCLOPROPANE ON THE NORMAL AND IMPAIRED LIVER.
    Raginsky BB; Bourne W
    Can Med Assoc J; 1934 Nov; 31(5):500-1. PubMed ID: 20319692
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of liver gluconeogenesis and CO2 production in both heart and liver by cyclopropane carboxylic acid in vitro.
    Bahl JJ; Shrago E; Brendel K; Bressler R
    Proc West Pharmacol Soc; 1978; 21():229-32. PubMed ID: 693501
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on the hypoglycaemic compound cyclopropanecarboxylic acid. Effects on gluconeogenesis in vitro.
    Duncombe WG; Rising TJ
    Biochem Pharmacol; 1972 Apr; 21(8):1089-96. PubMed ID: 4338304
    [No Abstract]   [Full Text] [Related]  

  • 40. The effects of cyclopropane carboxylate on hepatic pyruvate metabolism.
    Steinhelper ME; Olson MS
    Arch Biochem Biophys; 1985 Nov; 243(1):80-91. PubMed ID: 3933432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.